MedTrace Logo

Study on Fistuloplasty Using Flow Measurement Guidance

NCT01643733 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2017-03-27

No results posted yet for this study

Summary

Hypothesis: The primary objective of this study is to assess whether using a flow measurement device, in this case the Transonics flow device, as an end-point to interventional treatment of diseased dialysis fistulae can help increase immediate treatment success in terms of quality of dialysis immediately following the treatment and increasing time to reintervention.

Conditions

  • End Stage Renal Failure on Dialysis
  • Renal Failure

Interventions

DEVICE

Using Flow measurements to guide fistula angioplasty (Transonics)

Transonics flow measurements in the fistula would be used to guide the fistula intervention

Sponsors & Collaborators

  • Richard Lindsay

    lead OTHER

Principal Investigators

  • David Valenti, MD · McGill University Health Centre/Research Institute of the McGill University Health Centre

  • Louis Boucher, MD · McGill University Health Centre/Research Institute of the McGill University Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01643733 on ClinicalTrials.gov